However, despite this, favourable MGMT promoter methylation status is unfortunately not sufficient to confer acceptable long-term survival, with 5-year survival rates even for patients with tumours with methylated MGMT promotor regions is only around 14% [4]. Here, MGMT is linked to neoplasm.